Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-02-02

Clinical Trial Update: Sumatriptan 4 mg Statdose in the Acute Treatment of Cluster Headache [Phase 4]

View source ↗

Summary

This report provides an update on a Phase 4 trial evaluating Sumatriptan 4 mg Statdose for the acute treatment of episodic and chronic cluster headache.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sumatriptan 4 mg Statdose (Sumatriptan)

Snippet

Sponsor: Diamond Headache Clinic | Conditions: Episodic Cluster Headache, Chronic Cluster Headache | Phase 4 | Status: UNKNOWN